Status:
RECRUITING
Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
Lead Sponsor:
Alzheimer's Disease and Related Disorders Association, Inc
Collaborating Sponsors:
American College of Radiology
The Critical Path Institute
Conditions:
Alzheimer Disease
Eligibility:
All Genders
18+ years
Brief Summary
The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) will collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved Alzheime...
Detailed Description
ALZ-NET is collecting longitudinal clinical and safety data for enrolled patients that are being evaluated for or being treated with novel FDA-approved AD therapies. ALZ-NET is a longitudinal registry...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient or patient's legally authorized representative (LAR) or proxy (e.g., spouse or legal guardian) has the ability to understand the purpose and risks of ALZ-NET and provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local patient privacy regulations.
- Patient is at least 18 years of age at the time of informed consent.
- Patient has a diagnosis of MCI or dementia with clinical suspicion of AD as contributing pathology and (1) is being evaluated for treatment or, (2) will be initiating treatment, or (3) has already initiated treatment with novel FDA-approved AD therapies in real-world clinical practice.
- If treatment is initiated at the time of consent, patient meets appropriate label requirements and treatment follows appropriate use recommendations for novel FDA-approved AD therapy/therapies.
- Patient's treating clinician has made the decision to provide clinical care or treatment prior to patient consent and independently of the purpose of ALZ-NET.
Exclusion
Key Trial Info
Start Date :
October 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2032
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT06170268
Start Date
October 20 2022
End Date
December 1 2032
Last Update
December 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Full List of Active Sites
Chicago, Illinois, United States, 60601